Ocuphire Pharma, Inc. Quarterly report pursuant to Section 13 or 15(d)

Quarterly report pursuant to Section 13 or 15(d)

Leases (Tables)

Leases (Tables)

3 Months Ended

Mar. 31, 2019

Leases [Abstract]

Summary Of Right Of Use Lease Assets And Lease Liabilities


Right-of-Use Assets		$	303,096

Operating Lease Liabilities
Current		$	113,531
Long Term			181,490
Total Operating Lease Liabilities		$	295,021

Scheduled Future Minimum Lease Payments


Year Ending December 31:
2019 (excluding the three months ended March 31, 2019)	$	99,819
2020		154,961
2021		78,437
Minimum lease payments		333,217
Less: Imputed interest		(38,196)
Present value of minimum lease payments		295,021
Less: current maturities of lease obligations		(113,531)
Long-term lease obligations	$	181,490